FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024

June 18, 2024

https://www.globenewswire.com/news-release/2024/06/18/2900347/33525/en/FibroGen-to-Host-Part-II-of-Virtual-KOL-Investor-Event-Series-to-Review-FG-3246-Development-Program-in-Metastatic-Castration-Resistant-Prostate-Cancer-on-June-26-2024.html

SAN FRANCISCO, June 18, 2024 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ:FGEN) today announced it will host the second part of its virtual KOL investor event series on Wednesday, June 26, 2024 at 10:00 AM ET. To register, click here.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.